These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38443037)

  • 1. Tongue Edema Caused by Taking Nifedipine Controlled-Release Tablets.
    Zhang W; Xing W; Ling L
    Neurol India; 2024 Jan; 72(1):195. PubMed ID: 38443037
    [No Abstract]   [Full Text] [Related]  

  • 2. Special feature: picture of the month. Ingestion of nifedipine sustained-release tablets.
    Kreiling KM; Hampers LC; Baum CR
    Arch Pediatr Adolesc Med; 2000 Nov; 154(11):1161-2. PubMed ID: 11074860
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe gastrointestinal dysfunction and retention of extended release nifedipine tablets.
    Smitz S; Bonnet V; Delporte JP
    J Am Geriatr Soc; 1998 May; 46(5):656-7. PubMed ID: 9588385
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-substitution of nifedipine slow-release preparations.
    Van Veenhuyzen D; Coetzee R
    S Afr Med J; 2002 Nov; 92(11):838, 840. PubMed ID: 12506575
    [No Abstract]   [Full Text] [Related]  

  • 5. Bezoar formed by fragments of extended-release nifedipine tablets.
    Shepherd MF
    Clin Pharm; 1993 Nov; 12(11):849-52. PubMed ID: 8275650
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Am J Hypertens; 2008 Aug; 21(8):948-54. PubMed ID: 18600215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nifedipine monotherapy in the hypertensive elderly: a placebo-controlled clinical trial.
    Schnapp P; Hermann H; Cernak P; Kahay J
    Curr Med Res Opin; 1987; 10(6):407-13. PubMed ID: 3552459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced proteinuria after cessation of long-acting, osmotic release nifedipine GITS in diabetic nephropathy.
    Hess B
    Nephrol Dial Transplant; 1997 Aug; 12(8):1772-3. PubMed ID: 9269678
    [No Abstract]   [Full Text] [Related]  

  • 9. Nifedipine GITS (gastrointestinal therapeutic system) bezoar.
    Prisant LM; Carr AA; Bottini PB; Kaesemeyer WH
    Arch Intern Med; 1991 Sep; 151(9):1868-9. PubMed ID: 1888255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and Bioequivalence of 2 Nifedipine Controlled-Release Tablets: A Randomized, Single-Dose, 2-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
    Xin L; Chen Q; Chen D; Li Y; Li Y; Wu Q; Zou Y; Wang W; Jia J; Yu C; Liu Y
    Clin Pharmacol Drug Dev; 2023 Nov; 12(11):1082-1088. PubMed ID: 37132398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nifedipine XL-induced dysuria.
    Patil K; Tabibian JH; Lake M; Sisson S
    Am J Med; 2012 Sep; 125(9):e3-4. PubMed ID: 22682792
    [No Abstract]   [Full Text] [Related]  

  • 12. Early side-effects of antihypertensive therapy: comparison of amlodipine and nifedipine retard.
    Bremner AD; Fell PJ; Hosie J; James IG; Saul PA; Taylor SH
    J Hum Hypertens; 1993 Feb; 7(1):79-81. PubMed ID: 8450526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and acute side-effects of nifedipine given as slow-release tablets or liquid-filled capsules.
    Saano V; Raatikainen O; Paronen P; Komulainen H
    Int J Clin Pharmacol Res; 1989; 9(4):247-54. PubMed ID: 2777428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk in esophageal obstruction with slow-release medications.
    Simko V; Joseph D; Michael S
    J Assoc Acad Minor Phys; 1997; 8(2):38-42. PubMed ID: 9167415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is nifedipine a suitable first-line treatment for essential hypertension in general practice?
    Sullivan FM; Murray TS; Gaw N; Langan JJ; Adams-Strump BJ
    Eur Heart J; 1987 Nov; 8 Suppl K():21-5. PubMed ID: 3330028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
    Fagan TC; Haggert BE; Liss C
    Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of nifedipine slow-release during sustained tocolysis.
    ter Laak MA; Roos C; Touw DJ; van Hattum PR; Kwee A; Lotgering FK; Mol BW; van Pampus MG; Porath MM; Spaanderman ME; van der Post JA; Papatsonis DN; van 't Veer NE
    Int J Clin Pharmacol Ther; 2015 Jan; 53(1):84-91. PubMed ID: 25407260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-release nifedipine bezoar identified one year after discontinuation.
    Niezabitowski LM; Nguyen BN; Gums JG
    Ann Pharmacother; 2000; 34(7-8):862-4. PubMed ID: 10928396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nifedipine-induced periorbital edema.
    Tordjman K; Rosenthal T; Bursztyn M
    Am J Cardiol; 1985 May; 55(11):1445. PubMed ID: 3993594
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
    Anschütz M; Wonnemann M; Schug B; Toal C; Donath F; Pontius A; Pauli K; Brendel E; Blume H
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.